Pet-Ct Applications In Thorax - Introduction And Basic Principles

Abstract

Positron Emission Tomography (PET) is a scintigraphic imaging modality where radiopharmaceuticals labeled with positron emitting radionuclides and CT entegrated PET (PET/CT) scanners are used. Although there are numerous PET radiopharmaceutical available in medical literature, F-18 labeled fluorodeoxyglucose (FDG) is the most frequently used PET radiopharmaceutical in routine clinical applications, which is capable of imaging majority of malignant solid tumors. However, Ga-68 labeled peptides have also been very popular recently, in particular for imaging of neuroendocrine tumors and prostate cancers. This special issue is dedicated for clinical applications of FDG-PET/CT imaging in the disease of thorax.